Main Media English

Get Latest News, India News, World News at Main Media English

Support Us

Study from IIT Kanpur Reveals Mechanism of Action of Cholesterol-Lowering Drug Niacin

Niacin is known for its ability to raise levels of “good” cholesterol or high-density lipoprotein cholesterol (HDL) in the body while flushing out the “bad” type or low-density lipoprotein cholesterol (LDL). However, it also raises risks of some skin issues.

IANS logo Reported By IANS |
Published On :

Researchers at the Indian Institute of Technology (IIT) Kanpur in a new study detailed how cholesterol-lowering drugs like Niacin work at a molecular level.

Niacin is known for its ability to raise levels of “good” cholesterol or high-density lipoprotein cholesterol (HDL) in the body while flushing out the “bad” type or low-density lipoprotein cholesterol (LDL). However, it also raises risks of some skin issues.

Also Read Story

IIT-K and Blockchain For Impact (BFI) Join Forces to Drive Healthcare Innovation in India

IIT Jodhpur Develops Versatile 3D-Printed Hybrid UAV Prototype for Land, Air, and Water Movement

US firm Micron & IIT Roorkee to develop highly skilled workforce in India

Govt launches ‘Chakshu’ portal to fight frauds through spam calls, messages

IIT Delhi, R Systems International to launch AI centre for sustainable systems

IIT Bombay Develops Innovative Low-Cost Thin Coating Material to Combat Extreme Heat

IIT Kanpur and NMTronics India to Establish Manufacturing and Skills Development Center

Esri India, CKS to train 5 lakh students in geospatial tech skills in 5 yrs

IIT Jodhpur’s 1st ‘Make in India’ breath sensor to detect alcohol, asthma

“Niacin is a commonly prescribed drug to lower bad cholesterol and triglycerides while increasing good cholesterol. However, in many patients, the drug causes side effects such as skin redness and itching, referred to as a flushing response. This leads to patients stopping their treatment with adverse effects on their cholesterol levels,” said Prof. Arun K. Shukla of the Department of Biological Sciences and Bioengineering, IIT Kanpur, in a statement.


To understand the side effects of Niacin, the team deployed the cutting-edge cryogenic-electron microscopy (cryo-EM) technology. Using the technology, they visualised the key receptor molecule — Hydroxycarboxylic acid receptor 2 (HCA2) — which Niacin and other related drugs activate.

The HCA2, also known as the niacin receptor or GPR109A, regulates fat-related and artery-clogging processes in the human body.

When the receptor gets activated, it can make the blood vessels widen. This explains why Niacin leads to some patients experiencing a red, flushing skin reaction.

The findings, published in the journal Nature Communications will lead to the development of new drugs to lower cholesterol with fewer side effects.

“The visualisation of the receptor molecule GPR109A’s interaction with Niacin at the molecular level lays the groundwork for creating new drugs that maintain efficacy while minimising undesirable reactions. The study results will also help in developing related drugs for cholesterol and drugs for other conditions such as multiple sclerosis,” Prof. Shukla said.

(This report is auto-generated from IANS news service. 'Main Media' holds no responsibility for its content.)

Get involved in bringing the ground realities of Seemanchal. Click the "Support Us" button to join our membership.

Support Us

Related News

Air India’s 737 MAX aircraft to be equipped with Collins’ advanced avionics

Cabinet Approves Up to 100% FDI in Space Sector

IIT Kanpur Partners with Conlis Global to Advance Indigenous Bone Regeneration Technology with New MoU

Satellite Cartosat-2 successfully re-entered Earth’s atmosphere: ISRO

Western himalayan region more prone to climate change-induced risk: IIT Madras

India Ranks Third in Digitalization Among G20 Nations, New Report Reveals

Leave a Reply

Your email address will not be published. Required fields are marked *